Zendia Receives BSFZ Seal for R&D Activities
Zendia has been awarded the BSFZ Seal in recognition of its in-house research and development activities.As a result, the company…
Zendia Raises €884,000 to Advance Malaria Diagnostics
Zendia GmbH has successfully completed a financing round on the private investor network Companisto, raising €884,000 to support the further…
US Patent Granted for Zendia’s Rapid Test Methodology in Pathogen Detection
We are thrilled to announce the approval of Zendia GmbH’s USA Patent WO2018002327 titled “Rapid Test for Detecting Pathogens and…
Zendia Targets Market Entry with Innovative Malaria Diagnostic Solution
Zendia GmbH is aiming to enter the market bolstered by a substantial grant of 290,000 Euros from the German Federal…
Joint Venture with Charité Universitätsmedizin & Berlin Johann Wolfgang Goethe University
InfectoTest® collaboration team received a positive answer from the ethics committee from Berlin and Frankfurt for the study protocol “Entwicklung…
Continued Commitment: BMBF Invests Further in InfectoTest®
We’re delighted to share that the commitment to innovative health solutions by the German Federal Ministry of Education and Research…
InfectoTest® Receives €1.1M BMBF Grant for Breakthrough Malaria Diagnostic Research
InfectoTest® team with Zendia GmbH as a project leader, are honoured to be the recipients of a generous €1.1 million…